A safety profile of medications used to treat Waldenström's macroglobulinemia.

Published in: Expert opinion on drug safety (2018)

Although WM has no many specific drugs, there are many possible therapies, including Ibrutinib, the first formally approved drug for this disorder.

Keyphrases